Log in to save to my catalogue

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men wit...

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men wit...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6a722e19e074d229423f0a27222ffe3

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy

About this item

Full title

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy

Publisher

London: BioMed Central Ltd

Journal title

BMC urology, 2020-09, Vol.20 (1), p.1-138, Article 138

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Initial prostate biopsy often fails to identify prostate cancer resulting in patient anxiety, especially when clinical features such as prostate specific antigen (PSA) remain elevated, leading to the need for repeat biopsies. Prostate biomarker tests, such as the ExoDx[TM] Prostate (IntelliScore), or EPI test, have been shown to provide...

Alternative Titles

Full title

A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a6a722e19e074d229423f0a27222ffe3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a6a722e19e074d229423f0a27222ffe3

Other Identifiers

ISSN

1471-2490

E-ISSN

1471-2490

DOI

10.1186/s12894-020-00712-4

How to access this item